Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Fexapotide TFA

🥰Excellent
Catalog No. TP3502
Alias NX-1207 TFA

Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

Fexapotide TFA

Fexapotide TFA

🥰Excellent
Catalog No. TP3502Alias NX-1207 TFA
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Bulk & Custom
Questions
View More

Resource Download

Product Introduction

Bioactivity
Description
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
SynonymsNX-1207 TFA
Chemical Properties
FormulaC90H163N27O25S.xC2HF3O2
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
All types of co-solvents required for the protocol, such asDMSO, PEG300/ PEG400, Tween 80, SBE-β-CD, corn oil are available for purchase on the TargetMol website with a simple click.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Fexapotide TFA | purchase Fexapotide TFA | Fexapotide TFA cost | order Fexapotide TFA | Fexapotide TFA formula